Please upgrade your browser to make full use of twiends.   chrome   firefox   ie   safari  
Want to get more twitter followers? Click here to watch our video.
$EDAP..$2.10 on the ask.. Will open down more than 50% on that negative ADCOM.
RT @meddevices EDAP's Ablatherm PMA falters at advisory committee over poor efficacy data
$HALO: Agency folks not thrilled w/ risk vs benefit considering other IG remedies available & legit risks developing antibodies against PH20
Retweeted by Sheff
$BIND..$9.17..positive catalysts and Value Drivers in 2014. Two data readouts for BIND-014.
$ARWR..June Analyst Day Presentation. Good info here.
$FATE Therapeutic pipeline. Interim update from Ph2 PUMA study of ProHema in pts w/ hematologic malignancies in H2.
$ARWR expected catalysts in 2014-2015. CEO was just on #CNBC recently.
$ICPT key clinical & regulatory milestones.
FDA guidance on use of surrogate endpoints for NASH. $ICPT
6-pack beer holster on waist! Got this for a buddy for his 40th b-day. In time for Fantasy Football season draft:)
$CNAT pipeline looks strong. Two solid catalysts in H2/2014.
Mixed market today especially w/ certain biotechs. Not buying this bio "rally " yet this morning w/ $IBB higher. Still bargains to be had.
$NKTR..under $11 here. Lots of catalysts in H2.
$TKMR..$12 is up 8% as they provide update on TKM Ebola Ph 1 clinical hold. They are preparing a complete response to the FDA by Q4, 2014.
$BMY & $PFE announce European approval of apixaban for new indication
$GALT is a Fatty Liver Flop —>… Nothing you didn’t get 1st on Twitter but pay it forward w/ some clicks, please.
Retweeted by Sheff
@SheffStation very much a beaten down stock. Has a great bounce potential. We will get some update on Aug 5 earnings. $OXGN
Retweeted by Sheff
$OXGN..$2.53 here
$PCYC..$122 up 13% today! Huge move here. Raised to outperform by Leerink.
$GALT,,$8 now.. $LJPC might pullback as well in their stock price. The pectin family are a pist off group here today!
$KBIO..$1.61 in AH. Been watching this one…
$KBIO KaloBios regains global rights to KB001-A, completes enrollment in phase 2 study: Full Story
Retweeted by Sheff
$EDAP..$3.90 getting smacked down hard today on the ADCOM notes. This is pre-catalyst move where it hit a high of $6.00.